+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Terbium-149 Market - Global Forecast 2026-2032- Product Image
Terbium-149 Market - Global Forecast 2026-2032- Product Image
Sale

Terbium-149 Market - Global Forecast 2026-2032

  • Report

  • 190 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6133107
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Terbium-149 Market is projected to reach USD 310.02 Million in 2026. It is expected to continue growing at a CAGR of 8.83%, reaching USD 514.06 Million by 2032.

Terbium-149: Executive Overview

Terbium-149 is a radioactive terbium isotope of interest in targeted alpha therapy because it can emit high-energy alpha particles while also offering diagnostic imaging potential through additional decay emissions. Its clinical and commercial relevance depends on reliable isotope production, radiochemical quality, rapid formulation, and delivery within applicable radiation-safety and medical regulations. The field remains closely linked to advances in radiopharmaceutical development, nuclear medicine infrastructure, and access to specialized research and treatment centers.

Production and Clinical Translation Are Reshaping the Landscape

The landscape is being transformed by efforts to move terbium-149 from specialized research into reproducible preclinical and clinical workflows. Key shifts include greater attention to accelerator- and reactor-based production routes, target-material availability, radiochemical separation, radionuclidic purity, and methods that preserve the isotope’s therapeutic and imaging characteristics. Translation also depends on standardized dosimetry, validated radiolabeling procedures, suitable chelators, supply-chain coordination, and clinical protocols that address the short practical handling window associated with radioactive materials.

Artificial Intelligence Strengthens Discovery, Planning, and Quality Control

Artificial intelligence can support the terbium-149 ecosystem by helping researchers prioritize molecular targets, analyze biological response data, optimize production parameters, and identify formulation conditions. Imaging algorithms may improve lesion segmentation, biodistribution assessment, and patient-specific dosimetry, while predictive models can assist treatment planning and isotope logistics. These applications require carefully curated datasets, transparent validation, radiation-physics oversight, and human review; AI cannot replace experimental confirmation, regulatory evidence, or clinical judgment.

Regional Insights: Infrastructure and Regulation Shape Access

North America combines advanced nuclear medicine research capacity with established clinical-trial infrastructure, although isotope access and regulatory coordination remain important considerations. Europe benefits from strong academic collaboration and coordinated radiopharmaceutical research, while the European regulatory environment places emphasis on quality, safety, and traceability. Asia-Pacific includes substantial nuclear science capabilities and expanding interest in targeted radiopharmaceuticals, with access differing across national systems. The Middle East is developing specialized healthcare and research capacity, while Africa faces uneven access to isotope production, imaging, and radiopharmacy infrastructure. Latin America has active nuclear medicine communities, but cross-border logistics, production continuity, and specialized workforce availability can influence translational progress.

Group Insights: Collaboration Networks Influence Development

ASEAN countries may benefit from shared training, regional radiopharmacy standards, and coordinated access to production and imaging facilities. BRICS members bring varied nuclear research, manufacturing, and clinical capabilities, creating opportunities for technical cooperation alongside differing regulatory requirements. The European Union supports collaborative research and harmonization efforts across participating health systems. G7 members generally have mature research, regulatory, and clinical infrastructure, but must still coordinate isotope supply and evidence-generation pathways. GCC states are investing in advanced healthcare capacity and can strengthen regional radiopharmaceutical capabilities through specialized centers and workforce development. NATO members span diverse national systems, making interoperability, emergency preparedness, and secure scientific collaboration relevant to radiopharmaceutical resilience.

Country Insights: National Capabilities Require Coordinated Development

Australia contributes nuclear science and radiopharmaceutical expertise, while Brazil and Mexico are important Latin American participants in nuclear medicine and clinical research. Canada and the United States have substantial research and treatment infrastructure, with continued attention needed for isotope production and clinical translation. China, Japan, South Korea, and India possess significant nuclear, pharmaceutical, or medical technology capabilities, though regulatory and supply-chain conditions differ. France, Germany, Italy, Spain, and the United Kingdom have strong academic and clinical traditions in radiopharmacy and nuclear medicine, supported by specialized institutions and collaborative networks. Russia retains relevant nuclear science capacity, while access to international inputs and cooperation can affect development pathways. Across these countries, progress depends on qualified personnel, validated production, consistent quality systems, and patient-centered clinical evidence.

Priorities for Industry Leaders

Industry leaders should establish diversified, quality-controlled isotope supply routes and invest in production methods that are reproducible at the scale required for clinical research. They should pair radiochemistry development with early dosimetry, toxicology, imaging, and manufacturing planning rather than treating these as late-stage activities. Partnerships among isotope producers, hospitals, academic laboratories, regulators, and logistics specialists can reduce translation barriers. Leaders should also develop region-specific compliance strategies, strengthen radiation-safety systems, use AI only within validated governance frameworks, and design clinical studies that demonstrate both therapeutic benefit and practical treatment feasibility.

Research Methodology for the Executive Summary

This summary uses a qualitative synthesis of established scientific and operational considerations surrounding terbium-149, including isotope characteristics, targeted alpha therapy requirements, radiopharmaceutical production, clinical translation, nuclear medicine infrastructure, regulatory considerations, and regional capability differences. The analysis treats the requested regions, country groups, and countries as geographic lenses rather than as indicators of quantified performance. It excludes market estimates, market sizing, market shares, forecasts, and company-specific claims, and emphasizes evidence domains that can be evaluated through peer-reviewed research, regulatory materials, technical production studies, and clinical-development documentation.

Conclusion: Build Evidence and Infrastructure Together

Terbium-149 offers a distinctive platform for investigating targeted alpha therapy with integrated therapeutic and diagnostic potential. Its advancement will depend less on a single technical breakthrough than on coordinated progress in isotope production, radiochemistry, dosimetry, clinical evidence, regulation, and specialized care delivery. Organizations that connect these capabilities early, maintain rigorous quality and safety controls, and collaborate across regions will be better positioned to translate terbium-149 research into responsible clinical applications.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Terbium-149 Market, by Type
7.1. Introduction
7.2. Diagnostic
7.3. Therapeutic
8. Terbium-149 Market, by Purity
8.1. Introduction
8.2. Carrier Added
8.3. Carrier Free
9. Terbium-149 Market, by Supply Form
9.1. Introduction
9.2. Powder
9.3. Solution
10. Terbium-149 Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Neurology
10.4. Oncology
10.4.1. Prostate Cancer
10.4.2. Thyroid Cancer
11. Terbium-149 Market, by End User
11.1. Introduction
11.2. Diagnostic Centers
11.3. Hospitals
11.4. Research Institutes
12. Terbium-149 Market, by Sales Channel
12.1. Introduction
12.2. Direct Sales
12.3. Distributors
12.4. Online
13. Terbium-149 Market, by Region
13.1. Introduction
13.2. Asia-Pacific
13.3. North America
13.4. Latin America
13.5. Europe
13.6. Middle East
13.7. Africa
14. Terbium-149 Market, by Group
14.1. Introduction
14.2. ASEAN
14.3. GCC
14.4. European Union
14.5. BRICS
14.6. G7
14.7. NATO
15. Terbium-149 Market, by Country
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. United Kingdom
15.7. Germany
15.8. France
15.9. Russia
15.10. Italy
15.11. Spain
15.12. China
15.13. India
15.14. Japan
15.15. Australia
15.16. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. Market Concentration Analysis, 2025
16.2.1. Concentration Ratio (CR)
16.2.2. Herfindahl Hirschman Index (HHI)
16.3. Recent Developments & Impact Analysis, 2025
16.4. Product Portfolio Analysis, 2025
16.5. Benchmarking Analysis, 2025
17. Company Profiles
17.1. China Rare Earth Group CO., LTD.
17.2. China Rare Earth Resources And Technology Co., Ltd.
17.3. Greenland Minerals Limited
17.4. Iluka Resources Limited
17.5. Kasei Optonix Ltd.
17.6. Lynas Rare Earths Limited
17.7. MP Materials Corp.
17.8. Resonac Holdings Corp.
17.9. Shenghe Resources Holding Co., Ltd.
17.10. Shin-Etsu Chemical Co., Ltd.
17.11. Tanbreez Mining Greenland AS
18. Key Experts
LIST OF FIGURES
FIGURE 1. Global Terbium-149 Market, Years Considered for the Study
FIGURE 2. Global Terbium-149 Market, Research Design
FIGURE 3. Global Terbium-149 Market, Research Framework
FIGURE 4. Global Terbium-149 Market, Data Triangulation
FIGURE 5. Global Terbium-149 Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Terbium-149 Market Size, by Type, 2025 vs 2032 (%)
FIGURE 7. Global Terbium-149 Market Size, by Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Terbium-149 Market Size, by Purity, 2025 vs 2032 (%)
FIGURE 9. Global Terbium-149 Market Size, by Purity, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Terbium-149 Market Size, by Supply Form, 2025 vs 2032 (%)
FIGURE 11. Global Terbium-149 Market Size, by Supply Form, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Terbium-149 Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Terbium-149 Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Terbium-149 Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Terbium-149 Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Terbium-149 Market Size, by Sales Channel, 2025 vs 2032 (%)
FIGURE 17. Global Terbium-149 Market Size, by Sales Channel, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Terbium-149 Market Size, by Region, 2025 vs 2032 (%)
FIGURE 19. Global Terbium-149 Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 20. Global Terbium-149 Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Terbium-149 Market Size, by Country, 2025 vs 2032 (%)
FIGURE 22. Global Terbium-149 Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 23. Global Terbium-149 Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Terbium-149 Market Segmentation & Coverage
TABLE 2. Global Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 3. Global Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 4. Global Diagnostic Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Diagnostic Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Diagnostic Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Therapeutic Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Therapeutic Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Therapeutic Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 11. Global Carrier Added Market Size, by Region, 2017-2032 (USD Million)
TABLE 12. Global Carrier Added Market Size, by Group, 2017-2032 (USD Million)
TABLE 13. Global Carrier Added Market Size, by Country, 2017-2032 (USD Million)
TABLE 14. Global Carrier Free Market Size, by Region, 2017-2032 (USD Million)
TABLE 15. Global Carrier Free Market Size, by Group, 2017-2032 (USD Million)
TABLE 16. Global Carrier Free Market Size, by Country, 2017-2032 (USD Million)
TABLE 17. Global Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 18. Global Powder Market Size, by Region, 2017-2032 (USD Million)
TABLE 19. Global Powder Market Size, by Group, 2017-2032 (USD Million)
TABLE 20. Global Powder Market Size, by Country, 2017-2032 (USD Million)
TABLE 21. Global Solution Market Size, by Region, 2017-2032 (USD Million)
TABLE 22. Global Solution Market Size, by Group, 2017-2032 (USD Million)
TABLE 23. Global Solution Market Size, by Country, 2017-2032 (USD Million)
TABLE 24. Global Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 25. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Prostate Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Prostate Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Prostate Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Thyroid Cancer Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Thyroid Cancer Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Thyroid Cancer Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 41. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 51. Global Direct Sales Market Size, by Region, 2017-2032 (USD Million)
TABLE 52. Global Direct Sales Market Size, by Group, 2017-2032 (USD Million)
TABLE 53. Global Direct Sales Market Size, by Country, 2017-2032 (USD Million)
TABLE 54. Global Distributors Market Size, by Region, 2017-2032 (USD Million)
TABLE 55. Global Distributors Market Size, by Group, 2017-2032 (USD Million)
TABLE 56. Global Distributors Market Size, by Country, 2017-2032 (USD Million)
TABLE 57. Global Online Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Online Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Online Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Asia-Pacific Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 62. Asia-Pacific Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 63. Asia-Pacific Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 64. Asia-Pacific Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 65. Asia-Pacific Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 66. Asia-Pacific Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 67. Asia-Pacific Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 68. Asia-Pacific Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 69. North America Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. North America Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 71. North America Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 72. North America Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 73. North America Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 74. North America Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 75. North America Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 76. North America Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 77. Latin America Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Latin America Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 79. Latin America Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 80. Latin America Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 81. Latin America Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 82. Latin America Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 83. Latin America Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 84. Latin America Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 85. Europe Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Europe Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 87. Europe Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 88. Europe Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 89. Europe Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 90. Europe Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 91. Europe Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 92. Europe Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 93. Middle East Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Middle East Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 95. Middle East Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 96. Middle East Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 97. Middle East Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Middle East Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 99. Middle East Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Middle East Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 101. Africa Terbium-149 Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Africa Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 103. Africa Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 104. Africa Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 105. Africa Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Africa Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 107. Africa Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 108. Africa Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 109. Global Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 110. ASEAN Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 111. ASEAN Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 112. ASEAN Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 113. ASEAN Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 114. ASEAN Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 115. ASEAN Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 116. ASEAN Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 117. ASEAN Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 118. GCC Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. GCC Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 120. GCC Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 121. GCC Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 122. GCC Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 123. GCC Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 124. GCC Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 125. GCC Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 126. European Union Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 127. European Union Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 128. European Union Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 129. European Union Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 130. European Union Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. European Union Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 132. European Union Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 133. European Union Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 134. BRICS Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 135. BRICS Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 136. BRICS Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 137. BRICS Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 138. BRICS Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 139. BRICS Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 140. BRICS Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. BRICS Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 142. G7 Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 143. G7 Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 144. G7 Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 145. G7 Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 146. G7 Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 147. G7 Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 148. G7 Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 149. G7 Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 150. NATO Terbium-149 Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 152. NATO Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 153. NATO Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 154. NATO Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. NATO Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 156. NATO Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. NATO Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 158. Global Terbium-149 Market Size, by Country, 2017-2032 (USD Million)
TABLE 159. United States Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 160. United States Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 161. United States Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 162. United States Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 163. United States Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. United States Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 165. United States Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 166. United States Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 167. Canada Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 168. Canada Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 169. Canada Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 170. Canada Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 171. Canada Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 172. Canada Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 173. Canada Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 174. Canada Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 175. Mexico Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 176. Mexico Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 177. Mexico Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 178. Mexico Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 179. Mexico Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 180. Mexico Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 181. Mexico Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 182. Mexico Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 183. Brazil Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 184. Brazil Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 185. Brazil Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 186. Brazil Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 187. Brazil Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 188. Brazil Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 189. Brazil Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 190. Brazil Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 191. United Kingdom Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 192. United Kingdom Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 193. United Kingdom Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 194. United Kingdom Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 195. United Kingdom Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 196. United Kingdom Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 197. United Kingdom Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 198. United Kingdom Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 199. Germany Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 200. Germany Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 201. Germany Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 202. Germany Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 203. Germany Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. Germany Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 205. Germany Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 206. Germany Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 207. France Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 208. France Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 209. France Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 210. France Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 211. France Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 212. France Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 213. France Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. France Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 215. Russia Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 216. Russia Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 217. Russia Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 218. Russia Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 219. Russia Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Russia Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 221. Russia Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 222. Russia Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 223. Italy Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 224. Italy Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 225. Italy Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 226. Italy Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 227. Italy Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. Italy Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 229. Italy Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Italy Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 231. Spain Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 232. Spain Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 233. Spain Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 234. Spain Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 235. Spain Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 236. Spain Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 237. Spain Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. Spain Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 239. China Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 240. China Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 241. China Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 242. China Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 243. China Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 244. China Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 245. China Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 246. China Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 247. India Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 248. India Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 249. India Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 250. India Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 251. India Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. India Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 253. India Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 254. India Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 255. Japan Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 256. Japan Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 257. Japan Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 258. Japan Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 259. Japan Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 260. Japan Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 261. Japan Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. Japan Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 263. Australia Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 264. Australia Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 265. Australia Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 266. Australia Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 267. Australia Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 268. Australia Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 269. Australia Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 270. Australia Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 271. South Korea Terbium-149 Market Size, 2017-2032 (USD Million)
TABLE 272. South Korea Terbium-149 Market Size, by Type, 2017-2032 (USD Million)
TABLE 273. South Korea Terbium-149 Market Size, by Purity, 2017-2032 (USD Million)
TABLE 274. South Korea Terbium-149 Market Size, by Supply Form, 2017-2032 (USD Million)
TABLE 275. South Korea Terbium-149 Market Size, by Application, 2017-2032 (USD Million)
TABLE 276. South Korea Terbium-149 Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 277. South Korea Terbium-149 Market Size, by End User, 2017-2032 (USD Million)
TABLE 278. South Korea Terbium-149 Market Size, by Sales Channel, 2017-2032 (USD Million)
TABLE 279. Global Terbium-149 Market Share, by Key Player, 2025
TABLE 280. Global Terbium-149 Market, Key Experts

Companies Mentioned

  • China Rare Earth Group CO., LTD.
  • China Rare Earth Resources And Technology Co., Ltd.
  • Greenland Minerals Limited
  • Iluka Resources Limited
  • Kasei Optonix Ltd.
  • Lynas Rare Earths Limited
  • MP Materials Corp.
  • Resonac Holdings Corp.
  • Shenghe Resources Holding Co., Ltd.
  • Shin-Etsu Chemical Co., Ltd.
  • Tanbreez Mining Greenland AS

Related Topics

Related Reports

Alpha Emitters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Alpha Emitters - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 185 Pages
  • Global
From
Medical Isotopes Market Report 2026 - Product Image

Medical Isotopes Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Alpha Emitters Market - Global Forecast 2026-2032 - Product Image

Alpha Emitters Market - Global Forecast 2026-2032

  • Report
  • 190 Pages
  • Global
From
Nuclear Medicine Radioisotopes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Nuclear Medicine Radioisotopes - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 189 Pages
  • Global
From
Radioisotopes for Nuclear Medicine Diagnosis & Treatment Market - Global Forecast 2026-2032 - Product Image

Radioisotopes for Nuclear Medicine Diagnosis & Treatment Market - Global Forecast 2026-2032

  • Report
  • 189 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.